中國醫藥大學機構典藏 China Medical University Repository, Taiwan:Item 310903500/921
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 29490/55136 (53%)
Visitors : 1999255      Online Users : 390
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version


    Please use this identifier to cite or link to this item: http://ir.cmu.edu.tw/ir/handle/310903500/921


    Title: 3-取代 9-芳基甲基咔唑類衍生物之合成與抗癌活性;Synthesis and anticancer activity of 3-substituted 9-arylmethylcarbazole derivatives
    Authors: 戴秀芳;Hsiu-Fang Tai
    Contributors: 中國醫藥大學：藥物化學研究所碩士班
    Keywords: 咔;唑類衍生物;抗癌;carbazole derivatives;anticancer
    Date: 2009-07-16
    Issue Date: 2009-08-13 09:37:19 (UTC+8)
    Abstract: 為延續本實驗室一系列carbazole類衍生物之化學合成及其抗癌活性的探討，著者合成一系列3,6-substituted 9-trimethoxybenzylcarbazole，以及9-trimethoxybenzyl以不同芳基甲基取代的carbazole衍生物，並探討所合成的化合物之抗癌活性。
    首先，合成方法以carbazole為起始物，與3,4,5-trimethoxybenzylchloride反應生成9-trimethoxybenzylcarbazole (1)，接著將化合物1以POCl3/DMF進行Vielsmeir formylation得化合物1a，將化合物1a以NaBH4進行還原反應得到化合物1d。將化合物1在AlCl3與醋酸酐存在下進行乙醯化反應，得單乙醯化合物1b及雙乙醯化合物1c。
    此外，另將carbazole與arylmethyl chloride反應，得到相對應的化合物9-arylmethyl carbazole (2-5)，將化合物2-5以POCl3/DMF進行Vielsmeir formylation得化合物2a-5a，接著將化合物2a-5a以NaBH4進行還原反應得到相對應的化合物2d-5d。
    將這些合成之化合物進行抗癌活性測試，結果顯示部分化合物具明顯的抗癌活性，其中化合物(9-(3,4,5-trimethoxybenzyl)-9H-carbazol-3-yl)methanol (1d)對血癌細胞HL-60及K562、肝癌細胞Hep3B、乳癌細胞MCF7、卵巢癌細胞2774及SKOV3、肺癌細胞H226、H460之抑制活性IC50皆可達10-7-10-9 M，因此化合物1d相當值得進一步探討其抗癌活性。

    In order to continue our investigation of novel anticancer agents and their anticancer activities, we synthesized a series of 3,6-substituted 9-trimethoxy benzylcarbazole and 9-arylmethylcarbazole and evaluated for their anticancer activities.
    Initially, reaction of carbazole and 3,4,5-trimethoxybenzylchloride yields 9-trimethoxybenzylcarbazole (1). Subsequently, compound 1 underwent Vielsmeir formylation by treating with POCl3/DMF to give compound 1a. Compound 1a underwent reduction by treating with NaBH4 to give compound 1d, and compound 1 was treated with AlCl3 /acetic anhydride yield monoacetyl product 1b and diacetyl product 1c.
    Furthermore, reaction of carbazole and arylmethyl chloride yields corresponding 9-arylmethylcarbazoles (2-5). Compounds 2-5 underwent Vielsmeir formylation by treating with POCl3/DMF to give corresponding compounds 2a-5a. Compounds 2a-5a underwent reduction by treating with NaBH4 to give corresponding compounds 2d-5d.
    These synthesized compounds were evaluated for their cytotoxicity. Some of these tested compounds were found to demonstrate significant cytotoxicity. The most potent compound (9-(3,4,5-trimethoxybenzyl)-9H-carbazol-3-yl)methanol (1d) demonstrated strong cytotoxic effect with IC50 values in 10-7 to 10-9 M against human leukemia cell HL-60, human hepatoma cell Hep3B, breast cancer cell MCF7, ovarian cancer cell 2774, SKOV3 and lung cancer cell H226, H460. Therefore compound 1d was selected for further investigation.
    Appears in Collections:[Graduate Institute of Pharmaceutical Chemistry] Theses & dissertations

    Files in This Item:

    File SizeFormat
    index.html0KbHTML22View/Open


    All items in CMUR are protected by copyright, with all rights reserved.

     

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback